Literature DB >> 20083622

The impact of impaired renal function on mortality in patients with acutely decompensated chronic heart failure.

Amalia Vaz Pérez1, Katrin Otawa, Arabel V Zimmermann, Martin Stockburger, Ursula Müller-Werdan, Karl Werdan, Hendrik B Schmidt, Hüseyin Ince, Mathias Rauchhaus.   

Abstract

AIMS: Acute heart failure syndromes, commonly recognized as de novo heart failure or acute decompensated chronic heart failure (ADHF), are characterized by a rapid onset or change in signs and symptoms of heart failure requiring urgent treatment. Coexisting renal dysfunction is associated with poor prognosis in these patients. We sought to determine whether renal impairment in particular and other admission factors in general predict long-term mortality after hospitalization for ADHF. METHODS AND
RESULTS: We studied 128 patients (age 63 + or - 12 years, 76% male) in NYHA class 2.6 + or - 0.7 with a left ventricular ejection fraction (LVEF) < or = 39%, hospitalized due to ADHF. Mortality rates (per 100 person-years) were 21.9 at 12 months and 12.0 at 60 months. We found that admission serum creatinine level was the best predictor of mortality after 1 (P < 0.001, log-transformed due to skewed distribution) and 5 years (P = 0.001), followed by creatinine clearance, the use of loop diuretics, and digoxin. Moreover, higher NYHA class, decreased body mass index (BMI) and increased levels of urea predicted 1 and 5 years mortality on univariate analysis. In the multivariate analysis, creatinine, NYHA class, and LVEF emerged as independent predictors of mortality after 1 year, whereas BMI and the use of diuretics did not reach significance (joint chi(2) = 29.40, P < 0.001). After 5 years, creatinine and NYHA class independently predicted all-cause mortality (joint chi(2) = 22.71, P < 0.001), but BMI and age did not remain significant.
CONCLUSION: Admission creatinine level strongly predicts medium- and long-term mortality after hospitalization in patients with ADHF, and serves as a cheap and fast clinical marker to identify patients at risk of death.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20083622     DOI: 10.1093/eurjhf/hfp184

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  8 in total

Review 1.  Renal biomarkers of kidney injury in cardiorenal syndrome.

Authors:  Mark Comnick; Areef Ishani
Journal:  Curr Heart Fail Rep       Date:  2011-06

2.  A New Method for Individualized Digoxin Dosing in Elderly Patients.

Authors:  Ana Martin-Suarez; David García González; Juan F Macías Núñez; Ramón Ardanuy Albajar; M Victoria Calvo Hernández
Journal:  Drugs Aging       Date:  2016-04       Impact factor: 3.923

Review 3.  Prognostic implications of renal dysfunction in patients hospitalized with heart failure: data from the last decade of clinical investigations.

Authors:  Filippo Brandimarte; Muthiah Vaduganathan; Gian Francesco Mureddu; Giuseppe Cacciatore; Hani N Sabbah; Gregg C Fonarow; Steven R Goldsmith; Javed Butler; Francesco Fedele; Mihai Gheorghiade
Journal:  Heart Fail Rev       Date:  2013-03       Impact factor: 4.214

Review 4.  Current and novel renal biomarkers in heart failure.

Authors:  Kevin Damman; Adriaan A Voors; Gerjan Navis; Dirk J van Veldhuisen; Hans L Hillege
Journal:  Heart Fail Rev       Date:  2012-03       Impact factor: 4.214

5.  Community burden and prognostic impact of reduced kidney function among patients hospitalized with acute decompensated heart failure: The Atherosclerosis Risk in Communities (ARIC) Study Community Surveillance.

Authors:  Kunihiro Matsushita; Lucia Kwak; Noorie Hyun; Marina Bessel; Sunil K Agarwal; Laura R Loehr; Hanyu Ni; Patricia P Chang; Josef Coresh; Lisa M Wruck; Wayne Rosamond
Journal:  PLoS One       Date:  2017-08-09       Impact factor: 3.240

6.  In-hospital and long-term mortality for acute heart failure: analysis at the time of admission to the emergency department.

Authors:  Carlo Lombardi; Giulia Peveri; Dario Cani; Federica Latta; Andrea Bonelli; Daniela Tomasoni; Marco Sbolli; Alice Ravera; Valentina Carubelli; Nicola Saccani; Claudia Specchia; Marco Metra
Journal:  ESC Heart Fail       Date:  2020-06-26

7.  Determinants of left ventricular function improvement for cardiac resynchronization therapy candidates.

Authors:  Jung Ae Hong; Sang Eun Lee; Seon-Ok Kim; Min-Seok Kim; Hae-Young Lee; Hyun-Jai Cho; Jin Oh Choi; Eun-Seok Jeon; Kyung-Kuk Hwang; Shung Chull Chae; Sang Hong Baek; Seok-Min Kang; Dong-Ju Choi; Byung-Su Yoo; Kye Hun Kim; Myeong-Chan Cho; Byung-Hee Oh; Jae-Joong Kim
Journal:  ESC Heart Fail       Date:  2021-12-29

8.  Efficiency of individual dosage of digoxin with calculated concentration.

Authors:  Li Zhao; Peng Yang; Pengmei Li; Xiaoxing Wang; Wangjun Qin; Xianglin Zhang
Journal:  Clin Interv Aging       Date:  2014-07-22       Impact factor: 4.458

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.